Diabetic Macular Edema (DME) Latest Advances

Find the Latest Research About Diabetic Macular Edema (DME)

Last Updated: 04/28/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 6599 publications

Visual Acuity and Durability Outcomes of Faricimab Compared With Other Anti-vascular Endothelial Growth Factor Agents Within Routine Clinical Practice for Diabetic Macular Edema.

Visual Acuity and Durability Outcomes of Faricimab Compared With Other Anti-vascular Endothelial Growth Factor Agents Within Routine Clinical Practice for Diabetic Macular Edema.

Journal: Journal of vitreoretinal diseases

Published: April 13, 2026

Dexamethasone implant and aflibercept combination therapy versus aflibercept monotherapy for diabetic macular edema: A prospective, comparative trial (COED trial).

Dexamethasone implant and aflibercept combination therapy versus aflibercept monotherapy for diabetic macular edema: A prospective, comparative trial (COED trial).

Journal: Retina (Philadelphia, Pa.)

Published: April 09, 2026

Macular Telangiectasia Type 2 With Bidirectional Neovascular Network.

Macular Telangiectasia Type 2 With Bidirectional Neovascular Network.

Journal: Retinal cases & brief reports

Published: April 07, 2026

An update on the port delivery system with ranibizumab for retinal diseases.

An update on the port delivery system with ranibizumab for retinal diseases.

Journal: Expert opinion on drug delivery

Published: April 06, 2026

Correction: Aflibercept 8 mg versus Faricimab Treat-and-Extend for Diabetic Macular Edema or Neovascular Age-Related Macular Degeneration: A Bayesian Fixed-Effect Network Meta-analysis of Clinical Trials.

Correction: Aflibercept 8 mg versus Faricimab Treat-and-Extend for Diabetic Macular Edema or Neovascular Age-Related Macular Degeneration: A Bayesian Fixed-Effect Network Meta-analysis of Clinical Trials.

Journal: Ophthalmology and therapy

Published: April 04, 2026

Assessing patients who are treated with intravitreal injections by ultra-wide field imaging versus slit lamp biomicroscopy.

Assessing patients who are treated with intravitreal injections by ultra-wide field imaging versus slit lamp biomicroscopy.

Journal: European journal of ophthalmology

Published: April 02, 2026

Multimodal AI fuses proteomic and EHR data for rational prioritization of protein biomarkers in diabetic retinopathy.

Multimodal AI fuses proteomic and EHR data for rational prioritization of protein biomarkers in diabetic retinopathy.

Journal: medRxiv : the preprint server for health sciences

Published: April 01, 2026

Association of the Social Deprivation Index With the Severity and Treatment of Diabetic Retinopathy.

Association of the Social Deprivation Index With the Severity and Treatment of Diabetic Retinopathy.

Journal: Journal of vitreoretinal diseases

Published: April 01, 2026

Racial and Ethnic Differences in Prevalence and Incidence of Diabetic Retinal Disease.

Racial and Ethnic Differences in Prevalence and Incidence of Diabetic Retinal Disease.

Journal: Retina (Philadelphia, Pa.)

Published: March 31, 2026

EFFICACY OF COMBINED DEXAMETHASONE IMPLANT AND NAVIGATED SUBTHRESHOLD MICROPULSE YELLOW LASER IN DIABETIC MACULAR EDEMA.

EFFICACY OF COMBINED DEXAMETHASONE IMPLANT AND NAVIGATED SUBTHRESHOLD MICROPULSE YELLOW LASER IN DIABETIC MACULAR EDEMA.

Journal: Retina (Philadelphia, Pa.)

Published: March 24, 2026

TL-TransUNet: An Improved Lightweight Semantic Segmentation Model of Macular Edema Lesions in Retinal OCT Images.

TL-TransUNet: An Improved Lightweight Semantic Segmentation Model of Macular Edema Lesions in Retinal OCT Images.

Journal: Big data

Published: March 23, 2026

Biomarkers of Diabetic Macular Edema on Optical Coherence Tomography After Cataract Surgery.

Biomarkers of Diabetic Macular Edema on Optical Coherence Tomography After Cataract Surgery.

Journal: Journal of vitreoretinal diseases

Published: March 23, 2026

Showing 1-12 of 6,599

Last Updated: 04/28/2026